Table 1.
Group | Time to paralysis (min) | Time to death (min) |
---|---|---|
SPE (50 mg/ml) | 45 ± 6 | 50 ± 3 |
SPE (100 mg/ml) | 24 ± 3 | 29 ± 4 |
SPE (200 mg/ml) | 5 ± 2 | 6 ± 1 |
Vehicle control | – | – |
Albendazole (10 mg/ml) | 19 ± 2 | 24 ± 1 |
Data are means ± SD. N = 7.
Group | Time to paralysis (min) | Time to death (min) |
---|---|---|
SPE (50 mg/ml) | 45 ± 6 | 50 ± 3 |
SPE (100 mg/ml) | 24 ± 3 | 29 ± 4 |
SPE (200 mg/ml) | 5 ± 2 | 6 ± 1 |
Vehicle control | – | – |
Albendazole (10 mg/ml) | 19 ± 2 | 24 ± 1 |
Data are means ± SD. N = 7.